Ascelia Pharma AB
STO:ACE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ascelia Pharma AB
STO:ACE
|
SE |
|
Powerchip Semiconductor Manufacturing Corp
TWSE:6770
|
TW |
|
Change Inc
TSE:3962
|
JP |
|
Connected IO Ltd
ASX:CIO
|
US |
|
CalAmp Corp
OTC:CAMPQ
|
US |
|
H
|
Halmont Properties Corp
XTSX:HMT
|
CA |
|
Janux Therapeutics Inc
NASDAQ:JANX
|
US |
|
A
|
AUK Corp
KRX:017900
|
KR |
|
DC Infotech and Communication Ltd
NSE:DCI
|
IN |
|
CuriosityStream Inc
NASDAQ:CURI
|
US |
|
S
|
S V Global Mill Ltd
BSE:535621
|
IN |
|
Aehr Test Systems
NASDAQ:AEHR
|
US |
|
Science in Sport PLC
LSE:SIS
|
UK |
|
M
|
Mackolik Internet Hizmetleri Ticaret AS
IST:MACKO.E
|
TR |
|
Northern Trust Corp
NASDAQ:NTRS
|
US |
|
Michigan Brewery Inc
OTC:BBUCQ
|
US |
|
Acquazzurra SpA
MIL:ACQ
|
IT |
|
A
|
Advent-AWI Holdings Inc
XTSX:AWI
|
CA |
|
Industrias Bachoco SAB de CV
BMV:BACHOCOB
|
MX |
|
GHCL Ltd
NSE:GHCL
|
IN |
Bankruptcy Probability
Ascelia Pharma AB's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ascelia Pharma AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Ascelia Pharma AB
STO:ACE
|
370.3m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ascelia Pharma AB's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ascelia Pharma AB has total debt of 72k SEK. This includes both short-term (0 SEK) and long-term (72k SEK) debt.
You can find a full breakdown on its Balance Sheet.
